Chugai Pharmaceutical Co., Ltd. (CHGCY)

Growth

Revenue 5Y15.17%
Revenue 3Y19.84%
EPS 5Y41.31%
EPS 3Y48.43%
Dividend 5Y25.42%
Dividend 3Y41.15%

Capital Efficiency

ROIC39.26%
ROE29.40%
ROA21.80%
ROTA22.14%

Capital Structure

Market Cap43.79B
EV0
Cash274.04B
Current Ratio3.21
Debt/Equity0.23
Net Debt/EBITDA-0.53
Show More

Income Statement

Select a metric from the list below to chart it

Dec '03
Dec '07
Dec '11
Dec '15
Dec '19
Income Statement
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
TTM
Revenue
3,263.9
3,552.5
3,843.1
3,788.8
4,115.6
4,466.8
5,286.5
6,062.8
7,702.3
8,811.4
Revenue % Chg.
8.3%
8.8%
8.2%
-1.4%
8.6%
8.5%
18.4%
14.7%
27.0%
28.8%
Cost of Revenue
1,440.5
1,680.1
1,850.8
1,910.2
1,958.2
2,025.0
2,049.9
2,106.8
2,605.1
2,880.6
Cost of Revenue % Chg.
11.5%
16.6%
10.2%
3.2%
2.5%
3.4%
1.2%
2.8%
23.7%
24.7%
Gross Profit
1,823.4
1,872.4
1,992.3
1,878.6
2,157.4
2,441.8
3,236.6
3,955.9
5,097.2
5,930.8
Gross Profit % Chg.
5.9%
2.7%
6.4%
-5.7%
14.8%
13.2%
32.6%
22.2%
28.8%
30.9%
Gross Profit Margin
55.9%
52.7%
51.8%
49.6%
52.4%
54.7%
61.2%
65.2%
66.2%
67.3%
Gross Profit Margin % Chg.
-2.2%
-5.7%
-1.6%
-4.4%
5.7%
4.3%
12.0%
6.6%
1.4%
1.6%
R&D Expenses
572.3
622.5
645.6
654.9
716.1
764.3
831.6
907.9
1,057.8
1,095.5
R&D Expenses % Chg.
34.8%
8.8%
3.7%
1.4%
9.3%
6.7%
8.8%
9.2%
16.5%
7.5%
Selling, General, & Admin Expenses
644.5
665.4
678.1
631.3
679.1
719.7
782.5
727.3
789.0
806.8
Selling, General, & Admin Expenses % Chg.
371.0%
3.2%
1.9%
-6.9%
7.6%
6.0%
8.7%
-7.1%
8.5%
5.8%
Operating Income
606.6
584.4
668.6
592.3
762.2
957.8
1,622.5
2,320.7
3,250.4
4,028.5
Operating Income % Chg.
3.0%
-3.7%
14.4%
-11.4%
28.7%
25.7%
69.4%
43.0%
40.1%
46.6%
Operating Income Margin
18.6%
16.5%
17.4%
15.6%
18.5%
21.4%
30.7%
38.3%
42.2%
45.7%
Operating Income Margin % Chg.
-4.8%
-11.5%
5.7%
-10.1%
18.5%
15.8%
43.1%
24.7%
10.2%
13.8%
Total Other Income/Expenses Net
-13.8
2.3
3.8
-18.8
-14.7
-22.1
-20.8
-23.4
-19.4
-19.3
Total Other Income/Expenses Net % Chg.
64.3%
-
61.3%
-
21.9%
51.0%
5.9%
12.5%
17.4%
9.0%
Income Before Tax
592.8
586.8
672.4
573.6
747.5
935.7
1,601.6
2,297.3
3,231.0
4,009.2
Income Before Tax % Chg.
2.2%
-1.0%
14.6%
-14.7%
30.3%
25.2%
71.2%
43.4%
40.6%
47.0%
Income Before Tax Margin
18.2%
16.5%
17.5%
15.1%
18.2%
20.9%
30.3%
37.9%
41.9%
45.5%
Income Before Tax Margin % Chg.
-5.7%
-9.1%
5.9%
-13.5%
20.0%
15.3%
44.6%
25.1%
10.7%
14.1%
Income Tax Expense
193.1
185.6
192.0
154.7
181.0
218.6
387.8
643.0
896.7
1,152.5
Income Tax Expense % Chg.
-4.8%
-3.9%
3.5%
-19.4%
17.0%
20.8%
77.4%
65.8%
39.5%
53.4%
Net Income
392.1
392.8
470.9
412.9
560.2
712.5
1,213.9
1,654.3
2,334.3
2,856.6
Net Income % Chg.
5.6%
0.2%
19.9%
-12.3%
35.7%
27.2%
70.4%
36.3%
41.1%
44.6%
Net Income Margin
12.0%
11.1%
12.3%
10.9%
13.6%
16.0%
23.0%
27.3%
30.3%
32.4%
Net Income Margin % Chg.
-2.5%
-8.0%
10.8%
-11.1%
24.9%
17.2%
43.9%
18.8%
11.1%
12.2%
Weighted Avg. Shares Out
3,267.1
3,270.3
3,274.6
3,277.1
3,279.2
3,282.1
3,282.1
3,286.9
3,288.3
3,289.4
Weighted Avg. Shares Out % Chg.
0.1%
0.1%
0.1%
0.1%
0.1%
0.1%
-
0.1%
0.0%
0.1%
EPS
0.1
0.1
0.1
0.1
0.2
0.2
0.4
0.5
0.7
0.9
EPS % Chg.
5.5%
0.1%
19.7%
-12.4%
35.6%
27.1%
70.2%
36.2%
41.0%
44.5%
Weighted Avg. Shares Out Dil
3,271.1
3,275.7
3,280.8
3,282.0
3,284.5
3,287.5
3,287.5
3,290.2
3,290.5
3,290.7
Weighted Avg. Shares Out Dil % Chg.
0.1%
0.1%
0.2%
0.0%
0.1%
0.1%
-
0.1%
0.0%
0.1%
EPS Diluted
0.1
0.1
0.1
0.1
0.2
0.2
0.4
0.5
0.7
0.9
EPS Diluted % Chg.
5.4%
0.0%
19.7%
-12.4%
35.6%
27.1%
70.3%
36.2%
41.1%
44.5%
Interest Income
-
-
4.3
8.6
-
-
-
-
-
-
Interest Income % Chg.
-
-
-
98.7%
-
-
-
-
-
-
Interest Expense
0.1
0.1
0.5
0.7
0.8
0.9
1.0
0.5
0.4
0.4
Interest Expense % Chg.
200.0%
-8.3%
509.1%
28.4%
27.9%
0.9%
12.6%
-50.4%
-22.6%
-
EBIT
592.7
586.7
676.2
581.5
746.7
934.8
1,600.7
2,296.8
3,230.6
4,008.7
EBIT % Chg.
1.7%
-1.0%
15.3%
-14.0%
28.4%
25.2%
71.2%
43.5%
40.7%
47.0%
EBIT Margin
18.2%
16.5%
17.6%
15.3%
18.1%
20.9%
30.3%
37.9%
41.9%
45.5%
EBIT Margin % Chg.
-6.1%
-9.1%
6.5%
-12.8%
18.2%
15.3%
44.7%
25.1%
10.7%
14.1%
Depreciation & Amortization
111.6
114.6
119.9
126.1
125.8
-
-
-
-
-
Depreciation & Amortization % Chg.
-5.5%
2.7%
4.6%
5.2%
-0.2%
-
-
-
-
-
EBITDA
704.3
701.3
796.1
707.6
872.5
934.8
1,600.7
2,296.8
3,230.6
4,008.7
EBITDA % Chg.
0.5%
-0.4%
13.5%
-11.1%
23.3%
7.1%
71.2%
43.5%
40.7%
47.0%
EBITDA Margin
21.6%
19.7%
20.7%
18.7%
21.2%
20.9%
30.3%
37.9%
41.9%
45.5%
EBITDA Margin % Chg.
-7.2%
-8.5%
4.9%
-9.8%
13.5%
-1.3%
44.7%
25.1%
10.7%
14.1%